Skip to main content

Sana Biotechnology aims to raise $150M in IPO

The Seattle-based gene therapy startup filed with the U.S. Securities and Exchange Commission on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.